Dealing With the Left Atrial Appendage for Stroke Prevention: Devices and Decision-Making

Heart Lung and Circulation

Volumn 26, Issue 9, 2017, Pages 918-925

  Phillips, Karen P ^a   Paul, Vince ^b  

^a GREENSLOPES PRIVATE HOSPITAL   (Australia)

^b FIONA STANLEY HOSPITAL   (Australia)

Author keywords

Amplatzer Cardiac plug; Atrial fibrillation; Device occlusion; Left atrial appendage; Stroke prevention; WATCHMAN

Indexed keywords

ANTICOAGULANT AGENT;

AMPLATZER VASCULAR PLUG; ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; BLEEDING; CARDIOVASCULAR MORTALITY; CHRONIC DRUG ADMINISTRATION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DEVICE APPROVAL; DEVICE SAFETY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MEDICAL DECISION MAKING; MEDICAL DEVICE COMPLICATION; MEDICAL TECHNOLOGY; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; RISK REDUCTION; SECONDARY PREVENTION; THROMBUS; CEREBROVASCULAR ACCIDENT; COMPLICATION; DECISION MAKING; DIAGNOSTIC IMAGING; EQUIPMENT DESIGN; HEART ATRIUM APPENDAGE; HEART SURGERY; PROCEDURES; SEPTAL OCCLUDER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; DECISION MAKING; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EQUIPMENT DESIGN; HUMANS; SEPTAL OCCLUDER DEVICE; STROKE;

EID: 85021231068     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2017.05.113     Document Type: Review

References (51)

1. Wolf, P.A., Abbott, R.D., Kannel, W.B., Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22 (1991), 983–988.
2. Lin, H.J., Wolf, P.A., Kelly-Hayes, M., Beiser, A.S., Kase, C.S., Benjamin, E.J., et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 27:10 (1996), 1760–1764.
3. Hart, R.G., Pearce, L.A., Aguilar, M.I., Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:12 (2007), 857–867.
4. DeWilde, S., Carey, I.M., Emmas, C., Richards, N., Cook, D.G., Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 92:8 (2006), 1064–1070.
5. Lackland, D.T., Roccella, E.J., Deutsch, A.F., Fornage, M., George, M.G., Howard, G., et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 45:1 (2014), 315–353.
6. Connolly, S.J., Ezekowitz, M.D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361 (2009), 1139–1151.
7. Patel, M.R., Mahaffey, K.W., Garg, J., Pan, G., Singer, D.E., Hacke, W., et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365 (2011), 883–891.
8. Granger, C.B., Alexander, J.H., McMurray, J.J., Lopes, R.D., Hylek, E.M., Hanna, M., et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365 (2011), 981–992.
9. Aberg, H., Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 185:May (5) (1969), 373–379.
10. Stoddard, M.F., Singh, P., Dawn, B., Longaker, R.A., Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 145:4 (2003), 676–682.
11. Blackshear, J.L., Odell, J.A., Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61:2 (1996), 755–759.
12. Anselmino, M., Scaglione, M., Di Biase, L., Gili, S., Santangeli, P., Corsinovi, L., et al. Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation. Heart Rhythm 11:Jan (1) (2014), 2–7.
13. Madden, J.L., Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. J Am Med Assoc 140:Jul (9) (1949), 769–772.
14. Healey, J.S., Crystal, E., Lamy, A., Teoh, K., Semelhago, L., Hohnloser, S.H., et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 150:Aug (2) (2005), 288–293.
15. Katz, E.S., Tsiamtsiouris, T., Applebaum, R.M., Schwartzbard, A., Tunick, P.A., Kronzon, I., Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol 36:Aug (2) (2000), 468–471.
16. Nakai, T., Lesh, M.D., Gerstenfeld, E.P., Virmani, R., Jones, R., Lee, R.J., Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation 105:May (18) (2002), 2217–2222.
17. Sievert, H., Lesh, M.D., Trepels, T., Omran, H., Bartorelli, A., Della Bella, P., et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 105:Apr (16) (2002), 1887–1889.
18. Ostermayer, S.H., Reisman, M., Kramer, P.H., Matthews, R.V., Gray, W.A., Block, P.C., et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 46 (2005), 9–14.
19. Holmes, D.R., Reddy, V.Y., Turi, Z.G., Doshi, S.K., Sievert, H., Buchbinder, M., et al. Percutaneous Closure Of The Left Atrial Appendage Versus Warfarin Therapy For Prevention of Stroke In Patients With Atrial Fibrillation: A Randomised Non-inferiority Trial. Lancet 374 (2009), 534–542.
20. Kar, S., Hou, D., Jones, R., Werner, D., Swanson, L., Tischler, B., et al. Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model. JACC Cardiovasc Interv 7 (2014), 801–809.
21. Reddy, V.Y., Sievert, H., Halperin, J., Doshi, S.K., Buchbinder, M., Neuzil, P., et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312:Nov (19) (2014), 1988–1998.
22. Reddy, V.Y., Holmes, D.R., Doshi, S.K., Neuzil, P., Kar, S., Safety of Percutaneous Left Atrial Appendage Closure. Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) Clinical Trial and the Continued Access Registry. Circulation 123 (2011), 417–424.
23. Holmes, D.R., Kar, S., Price, M.J., Whisenant, B., Sievert, H., Doshi, S., et al. Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy: The PREVAIL Trial. J Am Coll Cardiol 64 (2014), 1–12.
24. Holmes, D.R. Jr, Doshi, S.K., Kar, S., Price, M.J., Sanchez, J.M., Sievert, H., et al. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. J Am Coll Cardiol 65:Jun (24) (2015), 2614–2623.
25. Reddy, V.Y., Mobius-Winkler, S., Miller, M.A., Neuzil, P., Schuler, G., Wiebe, J., et al. Left Atrial Appendage Closure With the Watchman Device in Patients With A Contraindication for Oral Anticoagulation. The ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 61 (2013), 2551–2556.
26. Boersma, L.V., Schmidt, B., Betts, T.R., Sievert, H., Tamburino, C., Teiger, E., et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J(Jan), 2016 pii: ehv730. [Epub ahead of print].
27. Phillips KP, Santoso T, Sanders P, Alison J, Chan JLK, Pak HN et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device in an Asian population: peri-procedural outcomes from the WASP registry. APHRS 2016, Seoul 2016.
28. Meier, B., Palacios, I., Windecker, S., Rotter, M., Cao, Q.L., Keane, D., et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 60:Nov (3) (2003), 417–422.
29. Park, J.W., Bethencourt, A., Sievert, H., Santoro, G., Meier, B., Walsh, K., et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 77:Apr (5) (2011), 700–706.
30. Freixa, X., Chan, J.L., Tzikas, A., Garceau, P., Basmadjian, A., Ibrahim, R., The Amplatzer™ Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. EuroIntervention 8:Jan (9) (2013), 1094–1098.
31. Tzikas, A., Shakir, S., Gafoor, S., Omran, H., Berti, S., Santoro, G., et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 11:Feb (10) (2016), 1170–1179.
32. Hildick-Smith, D., Amulet Observational Study: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial FibrillationTCT. 2016 Washington DC.
33. Reddy VY. Left atrial appendage closure with the Coherex WaveCrest left atrial appendage closure device. PCR 2013. Paris 2013.
34. Bartus, K., Han, F.T., Bednarek, J., Myc, J., Kapelak, B., Sadowski, J., et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol 62:Jul (2) (2013), 108–118.
35. (last accessed February 19 2017) http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454501.htm.
36. Price, M.J., Gibson, D.N., Yakubov, S.J., Schultz, J.C., Di Biase, L., Natale, A., et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol 64:Aug (6) (2014), 565–572.
37. Miller, M.A., Gangireddy, S.R., Doshi, S.K., Aryana, A., Koruth, J.S., Sennhauser, S., et al. Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device. Heart Rhythm 11:Nov (11) (2014), 1853–1859.
38. (last accessed February 19 2017) http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=3281669&pc=GAT.
39. Lam, Y.Y., Yan, B.P., Doshi, S.K., Li, A., Zhang, D., Kaya, M.G., et al. Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre™ device) in a canine model. Int J Cardiol 168:Oct (4) (2013), 3996–4001.
40. Lempereur, M., Aminian, A., Freixa, X., Gafoor, S., Kefer, J., Tzikas, A., et al. Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv(Feb), 2017, 10.1002/ccd.26903 [Epub ahead of print].
41. Camm, A.J., Lip, G.Y., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S.H., et al. ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:Nov (21) (2012), 2719–2747.
42. (last accessed February 19 2017) http://www.accessdata.fda.gov/cdrh_docs/pdf13/p130013a.pdf.
43. Anderson, J.L., Halperin, J.L., Albert, N.M., Bozkurt, B., Brindis, R.G., Curtis, L.H., et al. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:May (18) (2013), 1935–1944.
44. Amorosi, S.L., Armstrong, S., Da Deppo, L., Garfield, S., Stein, K., The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation. Europace 16:Aug (8) (2014), 1131–1136.
45. Reddy, V.Y., Akehurst, R.L., Armstrong, S.O., Amorosi, S.L., Brereton, N., Hertz, D.S., et al. Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Europace 18:Jul (7) (2016), 979–986.
46. Singh, S.M., Micieli, A., Wijeysundera, H.C., Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. Circulation 127:Jun (24) (2013), 2414–2423.
47. ® left atrial appendage occlusion procedures: Five-year experience. J Arrhythm 32 (2016), 119–126.
48. Alipour, A., Swaans, M.J., van Dijk, V.F., Balt, J.C., Post, M.C., Bosschaert, M.A.R., et al. Ablation for Atrial Fibrillation Combined With Left Atrial Appendage Closure. JACC: Clinical Electrophysiol 1 (2015), 486–495.
49. Romanov, A., Pokushalov, E., Artemenko, S., Yakubov, A., Stenin, I., Kretov, E., et al. Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial. J Interv Card Electrophysiol 44 (2015), 9–16.
50. Meier, B., Blaauw, Y., Khattab, A., EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace 10 (2015), 1109–1125.
51. Khattab, A.A., Gloekler, S., Sprecher, B., Shakir, S., Guerios, E., Stortecky, S., et al. Feasibility and outcomes of combined transcatheter aortic valve replacement with other structural heart interventions in a single session: a matched cohort study. Open Heart, 1(Jun (1)), 2014, e000014.